Article Reprints

STI
PDF Reprint 38-OS-Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study
$115.00

$115.00
Article Reprints